semaglutide cancer risk GLP-1 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely How Semaglutide May Reduce The

for me and my kids. They werent doing well either

Suboptimal dosing : Patients may be on a dose intended for diabetes management (0.5-1.0 mg weekly) rather than the higher dose approved for weight loss (2.4 mg weekly)

You may also want to discuss fertility, contraception, missed periods, heavy bleeding, and whether any additional testing is recommended

Thats why we take an individualized approach when creating a weight loss plan

These variants do not predict exact medication response but may provide context for why some individuals show different baseline weight, glucose metabolism, or appetite regulation patterns

International union of pharmacology